NASDAQ:ACT

Enact (ACT) Price, Holdings, & News

$29.95
+0.01 (+0.03%)
(As of 04/26/2024 08:52 PM ET)
Today's Range
$29.90
$30.10
50-Day Range
$26.70
$31.18
52-Week Range
$21.81
$31.26
Volume
121,100 shs
Average Volume
286,458 shs
Market Capitalization
$4.73 billion
Assets Under Management
$12.40 million
Dividend Yield
2.14%
Net Expense Ratio
0.75%
ACT stock logo

About Enact (NASDAQ:ACT)

Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.

ACT Stock Price History

ACT ETF News Headlines

His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
See More Headlines
Receive ACT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enact and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
AdvisorShares
Fund Name
AdvisorShares Vice ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:ACT
Inception Date
12/12/2017
Fund Manager
Dan S. Ahrens, Robert M. Parker

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$12.40 million
Average Daily Volume
$1,652.50
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
AdvisorShares Investments, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
0.58
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Enact Expenses

TypeACTTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.57%0.54%0.48%0.51%
Other Expenses0.31%0.72%0.54%0.34%0.58%
Total Expense0.91%0.72%0.70%0.58%0.70%
Fee Waiver-0.16%-0.76%-0.55%-0.22%-0.57%
Net Expense0.75%0.59%0.60%0.54%0.58%

Enact (ACT) Exposure

ACT Sector Exposure

ACT Industry Exposure


ACT ETF - Frequently Asked Questions

Should I buy or sell Enact stock right now?

0 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Enact in the last year. There are currently for the stock. The consensus among Wall Street research analysts is that investors should "n/a" ACT shares.
View ACT analyst ratings
or view top-rated stocks.

What is Enact's stock price target for 2024?

0 analysts have issued 12 month target prices for Enact's stock. Their ACT share price targets range from $0.00 to $0.00. On average, they expect the company's share price to reach $0.00 in the next year. This suggests that the stock has a possible downside of 100.0%.
View analysts price targets for ACT
or view top-rated stocks among Wall Street analysts.

How have ACT shares performed in 2024?

Enact's stock was trading at $28.89 at the start of the year. Since then, ACT shares have increased by 3.7% and is now trading at $29.95.
View the best growth stocks for 2024 here
.

Are investors shorting Enact?

Enact saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 884,300 shares, a decrease of 13.3% from the March 31st total of 1,020,000 shares. Based on an average daily volume of 281,400 shares, the short-interest ratio is presently 3.1 days. Approximately 2.9% of the shares of the company are sold short.
View Enact's Short Interest
.

When is Enact's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our ACT earnings forecast
.

How can I listen to Enact's earnings call?

Enact will be holding an earnings conference call on Thursday, May 2nd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Enact's earnings last quarter?

Enact Holdings, Inc. (NASDAQ:ACT) announced its quarterly earnings data on Tuesday, February, 6th. The company reported $0.98 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.08. The business earned $296.19 million during the quarter, compared to analysts' expectations of $303.58 million. Enact had a net margin of 57.69% and a trailing twelve-month return on equity of 15.23%. During the same period last year, the company posted $0.90 EPS.

How often does Enact pay dividends? What is the dividend yield for Enact?

Enact declared a quarterly dividend on Tuesday, February 20th. Investors of record on Wednesday, February 28th will be paid a dividend of $0.16 per share on Wednesday, March 13th. This represents a $0.64 annualized dividend and a dividend yield of 2.14%. The ex-dividend date of this dividend is Tuesday, February 27th.
Read our dividend analysis for ACT
.

What does ACT invest in?

Enact is a equity fund issued by AdvisorShares. ACT focuses on theme investments. The fund's investments total to approximately $12.40 million assets under management.

What is the management fee for Enact?

Enact's management fee is 0.60% and has other expenses of 0.31%. However, ACT has a fee waiver of -0.16% to reimburse the expenses. The net expense ratio for ACT is 0.75%.

What is Dave Page's approval rating as Enact's CEO?

12 employees have rated Enact Chief Executive Officer Dave Page on Glassdoor.com. Dave Page has an approval rating of 100% among the company's employees. This puts Dave Page in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Enact own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Enact investors own include Cara Therapeutics (CARA), Cronos Group (CRON), Innovative Industrial Properties (IIPR), Amplify Alternative Harvest ETF (MJ), Organigram (OGI), Tilray (TLRY), Zynerba Pharmaceuticals (ZYNE) and

When did Enact IPO?

Enact (ACT) raised $253 million in an initial public offering on Thursday, September 16th 2021. The company issued 13,310,400 shares at a price of $19.00 per share.

Who are Enact's major shareholders?

Enact's stock is owned by many different institutional and retail investors. Top institutional investors include Denali Advisors LLC (0.11%), Measured Wealth Private Client Group LLC (0.02%), Renaissance Capital LLC (0.01%) and Allspring Global Investments Holdings LLC (0.01%). Insiders that own company stock include Anne G Waleski, Brian Gould, Dominic James Addesso, Genworth Holdings, Inc, Hardin Dean Mitchell and Rohit Gupta.
View institutional ownership trends
.

How do I buy shares of Enact?

Shares of ACT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACT) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners